Holdings of Tema Oncology ETF
Tema ETF Trust · 55 declared positions · as of Feb 28, 2026
Original filing · Net assets 159.9M $ · Ten largest lines: 44.1 % of the equity sleeve
Country breakdown
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 46 | 123.2M $ | 77.61 % |
| CH | 2 | 14.4M $ | 9.08 % |
| GB | 1 | 7.4M $ | 4.66 % |
| KY | 3 | 5.4M $ | 3.41 % |
| DK | 1 | 5M $ | 3.15 % |
| JP | 1 | 2.1M $ | 1.29 % |
| NL | 1 | 1.3M $ | 0.80 % |
Sector breakdown is published in no regulatory filing: neither Form N-PORT nor the LEI reference data carries an activity code. It is absent rather than estimated.
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Revolution Medicines Inc | 98,581 | 10.1M $ | 6.29 % |
| Novartis AG | 46,684 | 7.9M $ | 4.96 % |
| Bridgebio Pharma Inc | 114,318 | 7.6M $ | 4.75 % |
| AstraZeneca PLC | 35,320 | 7.4M $ | 4.63 % |
| Eli Lilly & Co | 6,565 | 6.9M $ | 4.32 % |
| Bristol-Myers Squibb Co | 108,187 | 6.7M $ | 4.22 % |
| Roche Holding AG | 108,952 | 6.5M $ | 4.06 % |
| Merck & Co Inc | 49,630 | 6.1M $ | 3.84 % |
| Arcellx Inc | 48,346 | 5.5M $ | 3.44 % |
| Cogent Biosciences Inc | 135,358 | 5.3M $ | 3.29 % |
| Nuvalent Inc | 49,239 | 5M $ | 3.14 % |
| Genmab A/S | 169,724 | 5M $ | 3.13 % |
| Immunome Inc | 195,451 | 4.3M $ | 2.67 % |
| Johnson & Johnson | 16,257 | 4M $ | 2.53 % |
| Celcuity Inc | 35,371 | 4M $ | 2.47 % |
| Amgen Inc | 10,122 | 3.9M $ | 2.46 % |
| AbbVie Inc | 16,712 | 3.9M $ | 2.43 % |
| Exelixis Inc | 79,639 | 3.5M $ | 2.19 % |
| Ideaya Biosciences Inc | 89,238 | 2.9M $ | 1.80 % |
| BEONE MEDICINES LTD | 8,960 | 2.8M $ | 1.78 % |
| Syndax Pharmaceuticals Inc | 127,353 | 2.8M $ | 1.73 % |
| CG oncology Inc | 45,885 | 2.7M $ | 1.69 % |
| ZAI LAB LTD | 121,279 | 2.3M $ | 1.46 % |
| Erasca Inc | 169,487 | 2.3M $ | 1.45 % |
| Zymeworks Inc | 96,723 | 2.3M $ | 1.41 % |
| LEGEND BIOTECH CORP | 115,409 | 2.2M $ | 1.37 % |
| Nuvation Bio Inc | 362,046 | 2.1M $ | 1.34 % |
| Halozyme Therapeutics Inc | 29,868 | 2.1M $ | 1.30 % |
| Chugai Pharmaceutical Co Ltd | 30,652 | 2.1M $ | 1.28 % |
| Summit Therapeutics Inc | 110,918 | 1.8M $ | 1.15 % |
| AnaptysBio Inc | 28,657 | 1.6M $ | 0.99 % |
| Nurix Therapeutics Inc | 97,555 | 1.6M $ | 0.97 % |
| Regeneron Pharmaceuticals, Inc. | 1,982 | 1.5M $ | 0.97 % |
| Corvus Pharmaceuticals Inc | 82,148 | 1.5M $ | 0.94 % |
| UroGen Pharma Ltd | 67,164 | 1.5M $ | 0.91 % |
| Relay Therapeutics Inc | 142,040 | 1.5M $ | 0.91 % |
| Gilead Sciences Inc | 9,272 | 1.4M $ | 0.86 % |
| Olema Pharmaceuticals Inc | 56,608 | 1.4M $ | 0.86 % |
| Day One Biopharmaceuticals Inc | 121,928 | 1.3M $ | 0.81 % |
| Argenx SE | 1,663 | 1.3M $ | 0.80 % |
| Terns Pharmaceuticals Inc | 28,018 | 1.2M $ | 0.74 % |
| Xencor Inc | 76,928 | 982.4K $ | 0.61 % |
| Tyra Biosciences Inc | 28,438 | 947.3K $ | 0.59 % |
| Guardant Health Inc | 10,008 | 939.8K $ | 0.59 % |
| Arcus Biosciences Inc | 45,953 | 936.1K $ | 0.59 % |
| ArriVent Biopharma Inc | 40,743 | 935.9K $ | 0.59 % |
| Immunocore Holdings PLC | 28,275 | 913.3K $ | 0.57 % |
| HUTCHMED China Ltd | 62,129 | 890.3K $ | 0.56 % |
| Monte Rosa Therapeutics Inc | 45,524 | 808.1K $ | 0.51 % |
| Cullinan Therapeutics Inc | 47,065 | 729.5K $ | 0.46 % |
| Compass Therapeutics Inc | 127,476 | 720.2K $ | 0.45 % |
| Janux Therapeutics Inc | 47,193 | 642.3K $ | 0.40 % |
| Natera Inc | 3,049 | 634.3K $ | 0.40 % |
| Arvinas Inc | 45,326 | 601.5K $ | 0.38 % |
| ORIC Pharmaceuticals Inc | 35,407 | 476.2K $ | 0.30 % |